Journal article

Vaccine Adjuvant Properties of Probiotic Bacteria

Paul V Licciardi, Mimi LK Tang

Discovery Medicine | DISCOVERY MEDICINE | Published : 2011

Abstract

Vaccine-preventable diseases are still responsible for the deaths of more than 1 million children under the age of 5 years annually, mostly in developing countries. A substantial number of these deaths are due to pneumococcal bacteria and infections with rotavirus. Important issues faced by the WHO, governments, vaccine manufacturers, and international organizations such as UNICEF and the Global Alliance for Vaccines and Immunization (GAVI) are the cost-effective introduction of these life-saving vaccines in resource-poor countries where there is a considerable disease burden, and achieving high rates of completion of vaccination schedules remains elusive. Problems with vaccine coverage and ..

View full abstract

Grants

Funding Acknowledgements

We acknowledge the financial support provided by the Victorian Government's Operational Infrastructure Support Program. P.V.L. is a recipient of an Australian National Health and Medical Research Council Training Fellowship.M.L.K.T. is Chairman of the Asia Pacific Immunoglobulins in Immunology Expert Group (APIIEG) which is supported by CSL Ltd., and is a member of the Nestle Nutrition Institute Medical Advisory Board, Australia/New Zealand. P.V.L. has no conflicts of interest to declare.